Balyasny Asset Management »

Adma Biologics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.9M 446k 19.99
2024-06-30 $17M 1.5M 11.18
2024-03-31 $392k 59k 6.60
2023-12-31 $146k 32k 4.52
2022-03-31 $262k 143k 1.83

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Microsoft Corporation Call Option (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Alphabet Cap Stk Cl A (GOOGL)
Amazon Call Option (AMZN)
Discover Financial Services Call Option (DFS)
Select Sector Spdr Tr Energy (XLE)
Meta Platforms Cl A Call Option (META)
Kellogg Company Call Option (K)
Hess Call Option (HES)

View all positions for Balyasny Asset Management

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Nuveen Asset Management
Geode Capital Management
D. E. Shaw & Co
Two Sigma Advisers
AWM Investment Company
American Century Companies
Deutsche Bank Aktiengesellschaft
Dimensional Fund Advisors
Renaissance Technologies
Perpetual
Two Sigma Investments

View all funds holding Adma Biologics